STAA241220P27500
- 0.93
- -0.32-25.60%
Staar Surgical Newsroom
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $38
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $49
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $42
Morgan Stanley Maintains Staar Surgical(STAA.US) With Sell Rating, Cuts Target Price to $27
Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Stevanato Group (STVN)
Oppenheimer Maintains Staar Surgical(STAA.US) With Hold Rating
A Quick Look at Today's Ratings for Staar Surgical(STAA.US), With a Forecast Between $31 to $49
Staar Surgical Price Target Cut to $31.00/Share From $41.00 by Canaccord Genuity
BTIG Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $49
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Piper Sandler Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $40
Mizuho Securities Maintains Staar Surgical(STAA.US) With Buy Rating, Announces Target Price $50
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Maintains Target Price $44
Needham Maintains Staar Surgical(STAA.US) With Hold Rating
Staar Surgical Price Target Cut to $44.00/Share From $50.00 by Stifel
Staar Surgical Analyst Ratings
Stifel Maintains Staar Surgical(STAA.US) With Buy Rating, Cuts Target Price to $44
CCORF Maintains Staar Surgical(STAA.US) With Hold Rating, Maintains Target Price $41
Analysts Conflicted on These Healthcare Names: Merus (MRUS), Staar Surgical (STAA) and Rani Therapeutics Holdings (RANI)
Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Staar Surgical (STAA) and Organon (OGN)